Table 1 Characteristics of samples used in this study.

From: Plasma proteomic analysis of stable coronary artery disease indicates impairment of reverse cholesterol pathway

VARIABLES

DISCOVERY PHASE

VERIFICATION PHASE

VALIDATION PHASE

CAD (n = 10)

CONTROL (n = 10)

CAD (n = 20)

CONTROL (n = 20)

CAD (n = 253)

CONTROL (n = 253)

p-VALUE*

HT-no.(%)

2(20)

2(20)

4(20)

1(5)

104(41.1)

38(15)

<0.0001

DM-no.(%)

2(20)

2(20)

6(30)

2(10)

78(30.8)

28(11)

<0.0001

SMOKING-no.(%)

Nil

Nil

6(30)

4(20)

114(45)

99(39.1)

0.177

DIET-veg.(%)

7(70)

9(90)

8(40)

9(45)

108(42.6)

121(47.8)

0.246

BMI (Kg/m2)

23.78 (22.0–24.85)

25.35 (21.76–27.11)

25.11 (23.3–28.28)

24.88 (22.43–28.8)

24.24 (22.57–26.52)

24.85 (22.58–27.43)

>0.05

STATIN-no.(%)

7(70)

0(0)

14(70)

0(0)

106(41.8)

0(0)

<0.0001

AGE-Mean(±SD)

56.25 ± 5.24

58.17 ± 4.21

50.05 ± 2.03

52.55 ± 5.10

51.74 ± 8.75

48.24 ± 10.36

<0.0001

  1. n = number of individuals, Mean ± standard deviation reported for continuous variables while number (percentage) reported for discrete variables. HT- Hypertension, DM-Diabetes Mellitus, *p-value = calculated using chi-square or Mann-Whitney test.
Back to article page